Comparison

Aprepitant

Manufacturer Adooq
Category
Type Inhibitors
Specific against other
Amount 5mg
Item no. A10083-5
eClass 6.1 30220300
eClass 9.0 32160605
Available
Short Description
Aprepitant is classified as an NK1 antagonist. Aprepitant has been shown to inhibit both the acute and delayed emesis induced by cytotoxic chemotherapeutic drugs by blocking substance P landing on receptors in the brains neurons. It has also been shown to increase the activity of the 5-HT3 receptor antagonists ondansetron and the corticosteroid dexamethasone, which are also used to prevent nausea and vomiting caused by chemotherapy.
Cas No
170729-80-3
Synonyms
MK0869, MK-869, L-754030, Emend
Formula
C23H21F7N4O3
Solubilty
DMSO
Purity
>98%
Chemical Name
5-([(2R, 3S)-2-((R)-1-[3, 5-bis(trifluoromethyl)phenyl]ethoxy)-3-(4-fluorophenyl) morpholino]methyl)-1H-1, 2, 4-triazol-3(2H)-one
M. Wt.
534, 4
SMILES
C[C@ H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@ @ H]2[C@ @ H](N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
Storage
2 years at -20C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
available

Delivery expected until 5/23/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close